Cargando…
MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location
Activating mutations of Kras oncogene and deletions of Pten tumor suppressor gene play important roles in cancers of the female genital tract. We developed here new preclinical models for gynecologic cancers, using conditional (Cre-loxP) mice with floxed genetic alterations in Kras and Pten. The tri...
Autores principales: | Tirodkar, Tejas S., Budiu, Raluca A., Elishaev, Esther, Zhang, Lixin, Mony, Jyothi T., Brozick, Joan, Edwards, Robert P., Vlad, Anda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117479/ https://www.ncbi.nlm.nih.gov/pubmed/25078979 http://dx.doi.org/10.1371/journal.pone.0102409 |
Ejemplares similares
-
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial to mesenchymal transition in ovarian cancer
por: Zhang, Lixin, et al.
Publicado: (2016) -
Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model
por: Budiu, Raluca A., et al.
Publicado: (2016) -
Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS(G12D) or KRAS(G12V) mutations
por: Kun, Eucharist H. S., et al.
Publicado: (2020) -
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
por: Grabosch, Shannon, et al.
Publicado: (2018) -
PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer
por: Grabosch, Shannon, et al.
Publicado: (2015)